Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors
I'm PortAI, I can summarize articles.
Inovio Pharmaceuticals Inc. (INO) shares fell 1.32% to $2.25 on Monday, underperforming compared to competitors like Johnson & Johnson and Pfizer. This marks the third consecutive day of losses for Inovio, with the stock closing 24.47% below its 52-week high. Trading volume was higher than the 50-day average. The NASDAQ and Dow Jones indices both rose during the session.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments